News & Announcements

The Medicines Patent Pool Signs New Round of Generic Manufacturing Licences for HIV and Hepatitis C Treatments

The Medicines Patent Pool Releases 2015 Annual Report: Five Years of Patent Pooling for Public Health

ViiV Healthcare, Medicines Patent Pool Extend Licence for Dolutegravir to all Lower Middle-Income Countries

Upcoming events

Wednesday 5 October

MPP, UNITAID and Chile’s National Institute of Industrial Property (INAPI) host side event, “Enhancing Patent and Licensing Transparency for Medicines,” during WIPO General Assemblies, 13:00-15:00

Recent Highlights

The MPP’s summer newsletter is out!

The MPP publishes its July 2016 newsletter featuring an update on its last six months of progress.

The New York Times – New strategies to fight AIDS

Letter to the editor from MPP’s Executive Director

Voluntary Patent Pooling: Encouraging Rapid Scale-Up of Medicines for Resource-Limited Countries

Read a blog post by Greg Perry, MPP’s Executive Director

Medicines Patent Pool statement, 69th World Health Assembly

Agenda item 15.1 – WHO Global Health Sector Strategies for HIV and Viral Hepatitis
MPP representative: Greg Perry
Full statement

Generics Bulletin: “Medicines Patent Pool has potential for wider scope”

Read the article